Executive Director, Global Commercial Lead, Lung Portfolio

BeiGene

13d•$269,400 - $349,400

About The Position

BeOne's Solid Tumor organization is advancing novel therapies in Breast/Gynecological, Gastrointestinal (GI), and Lung Cancers. With over 20 clinical candidates advanced in the past three years, the company is presenting proof-of-concept data on two Lung Franchise assets before the end of 2026. BeOne is establishing Global Product Teams (GPTs) for registration-intent studies and will soon form corresponding Global Brand Teams (GBTs) for successful global commercial launches. This highly visible role will serve as the Global Brand Leader (GBL) for two Lung Cancer assets transitioning to late-stage development. The GBL will mobilize the first GBTs for these assets, comprising members from various functions and markets, to create global brand plans. These plans will define the opportunity size, commercial strategies, and tactical implementation for successful global launches. The role requires a visionary leader recognized at the R&D and commercial interface, with strong collaboration skills to ensure alignment with business objectives and market needs across functions and BeOne Regions. A deep understanding of drug development and commercialization, strong leadership, and a proven track record in leading matrix teams for product launch and LCM planning are essential. The role reports to the Vice President, Global Commercial Strategy & Operations (GCSO), Solid Tumors.

Requirements

12+ years of experience in pharmaceutical marketing/healthcare-related commercial experience, inclusive of 5+ years in oncology/hematology.
5+ years of Global Marketing/New Product Planning experience.
Demonstrated experience in leading brand strategy/new product planning at various stages of the product lifecycle.
Product launch experience, either from a Global-based role or Market-based role
Advanced or expert competency in solid tumors and highly competitive markets
Strong team player who can incorporate input from key stakeholders (both internally and externally) and drive cross-regional and cross-functional alignment.
Proven ability to inspire, motivate and lead high-performing, matrixed teams.
Highly-skilled and effective in engaging, connecting, and influencing across all levels from senior leadership to local marketing teams.
Understanding of change management principles and experience driving change across an organization.
Strong ability and desire to work across time zones, geographies, and cultures to improve the lives of patients and caregivers.
Bachelor’s Degree in Marketing, Sciences, or a related field

Nice To Haves

15+ years of experience in pharmaceutical marketing/healthcare-related commercial experience, inclusive of 5+ years in Global Marketing/New Product Planning for oncology/hematology.
Demonstrated understanding in the reimbursement considerations for medicines across the major markets (US/EU5/Japan/China)
In-country experience in a major market (US/EU5/Japan/China)
Previous international assignments
Master’s Degree in Business (MBA) or PhD

Responsibilities

Provide strategic leadership for two late-stage Lung Cancer-focused assets, overseeing global commercial strategies, serving as the commercial voice at the Global Product Team (GPT), and representing the Brand across BeOne territories, with senior leadership, and with external stakeholders.
Lead the Global Brand Team (GBT) ensuring productive information exchange and best practice sharing between GPT, GBT, and regional / affiliate team members.
Develop an aligned view of brand growth drivers and ensure progress to plan consistent with agreed business objectives.
Represent ONE commercial voice to Global Product Team (GPT), R&D, Tech Ops, Executive Leadership, and Solid Tumor Franchise Teams to drive organizational alignment and progress.
Lead key cross-functional processes including the Annual Brand Plan, the Annual Operating Plan (AOP), and the Long-Range Plan (LRP) processes.
Build, inspire, and develop talent within the global commercial team as BeOne resources the brand teams through launch preparations and commercialization.
Collaborate with cross-regional and cross-functional team members to shape brand strategies for multiple indications to form an integrated view of lifecycle management priorities.
Integrate major market input into global launch readiness plans and support the implementation / execution of global commercial strategies in local markets.
Ensure long-term growth by translating complex clinical evidence into a unified global narrative that drives market leadership.
Consolidate competitor understanding that spans multiple modalities and indications into a cohesive product view.
Develop succinct competitive response plans that are grounded in a deep understanding of marketplace performance and competitor strategies.
Collaborate with functional leads to ensure insight generation that helps drive business performance, and develop and maintain a Global Brand Dashboard.
Lead the cross-functional team to execute launch readiness preparations and discussions with GBT member markets.
Drive value maximization and recommend growth strategies to meet long-term Solid Tumor portfolio ambitions.
Collaborate with Medical Affairs, Regions, and Corporate Communications to craft and refine stakeholder communications.
Partner with Tech Ops to ensure optimized supply and demand management.
Maintain strong relationships with both internal colleagues and external customers and thought leaders to address market opportunities.